{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T13:21:42Z","timestamp":1793020902437,"version":"4.5.0"},"reference-count":156,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T00:00:00Z","timestamp":1741564800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s11060-025-05001-4","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T13:32:03Z","timestamp":1741613523000},"page":"275-288","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["The spectrum of radiation therapy options for craniopharyngioma: a systematic review"],"prefix":"10.1007","volume":"173","author":[{"given":"Paul M.","family":"Harary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeeth","family":"Rajaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke S.","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,10]]},"reference":[{"key":"5001_CR1","doi-asserted-by":"publisher","first-page":"CASE21642","DOI":"10.3171\/CASE21642","volume":"3","author":"AL Slingerland","year":"2022","unstructured":"Slingerland AL, Baird LC, Scott RM (2022) Optic nerve compression in craniopharyngioma by Taut anterior cerebral arteries visualized in frontal and transsphenoidal exposures: illustrative cases. J Neurosurg Case Lessons 3:CASE21642. https:\/\/doi.org\/10.3171\/CASE21642","journal-title":"J Neurosurg Case Lessons"},{"key":"5001_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2147\/IMCRJ.S295848","volume":"14","author":"ND Hung","year":"2021","unstructured":"Hung ND, Ngan VK, Duc NM (2021) Intrinsic third ventricular papillary craniopharyngioma: A report of five cases and literature review. Int Med Case Rep J 14:83\u201387. https:\/\/doi.org\/10.2147\/IMCRJ.S295848","journal-title":"Int Med Case Rep J"},{"key":"5001_CR3","first-page":"193","volume":"69","author":"HL M\u00fcller","year":"2008","unstructured":"M\u00fcller HL (2008) Childhood craniopharyngiomarecent advances in diagnosis, treatment and Follow-Up. Horm Res 69:193\u2013202","journal-title":"Horm Res"},{"key":"5001_CR4","doi-asserted-by":"crossref","unstructured":"M\u00fcller HL (2014) Craniopharyngioma Endocr Reviews 35:513\u2013543","DOI":"10.1210\/er.2013-1115"},{"key":"5001_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41572-019-0125-9","volume":"5","author":"HL M\u00fcller","year":"2019","unstructured":"M\u00fcller HL, Merchant TE, Warmuth-Metz M et al (2019) Craniopharyngioma. Nat Reviews Disease Primers 5:75. https:\/\/doi.org\/10.1038\/s41572-019-0125-9","journal-title":"Nat Reviews Disease Primers"},{"key":"5001_CR6","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/S0090-3019(03)00132-0","volume":"60","author":"S Behari","year":"2003","unstructured":"Behari S, Banerji D, Mishra A et al (2003) Intrinsic third ventricular craniopharyngiomas: report on six cases and a review of the literature. Surg Neurol 60:245\u2013252","journal-title":"Surg Neurol"},{"key":"5001_CR7","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3171\/jns.1998.89.4.0547","volume":"89","author":"GR Bunin","year":"1998","unstructured":"Bunin GR, Surawicz TS, Witman PA et al (1998) The descriptive epidemiology of craniopharyngioma. J Neurosurg 89:547\u2013551","journal-title":"J Neurosurg"},{"key":"5001_CR8","first-page":"1070","volume":"14","author":"BE Zacharia","year":"2012","unstructured":"Zacharia BE, Bruce SS, Goldstein H et al (2012) Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program. Neurooncology 14:1070\u20131078","journal-title":"Neurooncology"},{"key":"5001_CR9","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1210\/jc.2014-3525","volume":"100","author":"DS Olsson","year":"2015","unstructured":"Olsson DS, Andersson E, Bryngelsson I-L et al (2015) Excess mortality and morbidity in patients with craniopharyngioma, especially in patients with childhood onset: a population-based study in Sweden. J Clin Endocrinol Metabolism 100:467\u2013474","journal-title":"J Clin Endocrinol Metabolism"},{"key":"5001_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1159\/000120861","volume":"21","author":"HJ Hoffman","year":"1994","unstructured":"Hoffman HJ (1994) Surgical management of craniopharyngioma. Pediatr NeuroSurg 21:44\u201349","journal-title":"Pediatr NeuroSurg"},{"key":"5001_CR11","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s11102-021-01127-6","volume":"24","author":"AA Momin","year":"2021","unstructured":"Momin AA, Recinos MA, Cioffi G et al (2021) Descriptive epidemiology of craniopharyngiomas in the united States. Pituitary 24:517\u2013522. https:\/\/doi.org\/10.1007\/s11102-021-01127-6","journal-title":"Pituitary"},{"key":"5001_CR12","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00401-018-1830-2","volume":"135","author":"JR Apps","year":"2018","unstructured":"Apps JR, Carreno G, Gonzalez-Meljem JM et al (2018) Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK\/ERK pathway as a novel therapeutic target. Acta Neuropathol 135:757\u2013777","journal-title":"Acta Neuropathol"},{"key":"5001_CR13","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1007\/s00401-005-1004-x","volume":"109","author":"R Buslei","year":"2005","unstructured":"Buslei R, Nolde M, Hofmann B et al (2005) Common mutations of \u03b2-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the Sellar region. Acta Neuropathol 109:589\u2013597","journal-title":"Acta Neuropathol"},{"key":"5001_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ng.2868","volume":"46","author":"PK Brastianos","year":"2014","unstructured":"Brastianos PK, Taylor-Weiner A, Manley PE et al (2014) Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nat Genet 46:161\u2013165","journal-title":"Nat Genet"},{"key":"5001_CR15","first-page":"126","volume":"76","author":"T Goschzik","year":"2017","unstructured":"Goschzik T, Gessi M, Dreschmann V et al (2017) Genomic alterations of adamantinomatous and papillary craniopharyngioma. J Neuropatholgy Experimental Neurol 76:126\u2013134","journal-title":"J Neuropatholgy Experimental Neurol"},{"key":"5001_CR16","first-page":"3","volume":"106","author":"S Puget","year":"2007","unstructured":"Puget S, Garnett M, Wray A et al (2007) Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement. J Neurosurgery: Pediatr 106:3\u201312","journal-title":"J Neurosurgery: Pediatr"},{"key":"5001_CR17","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00701-004-0295-3","volume":"146","author":"J Pascual","year":"2004","unstructured":"Pascual J, Gonz\u00e1lez-Llanos F, Barrios L, Roda J (2004) Intraventricular craniopharyngiomas: topographical classification and surgical approach selection based on an extensive overview. Acta Neurochir 146:785\u2013802","journal-title":"Acta Neurochir"},{"key":"5001_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3171\/2014.3.FOCUS1464","volume":"37","author":"JM Pascual","year":"2014","unstructured":"Pascual JM, Prieto R, Carrasco R et al (2014) Letters to the editor: craniopharyngioma adherence to the hypothalamus. NeuroSurg Focus 37:1\u20139","journal-title":"NeuroSurg Focus"},{"key":"5001_CR19","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.3171\/2016.9.FOCUS16304","volume":"41","author":"R Prieto","year":"2016","unstructured":"Prieto R, Pascual JM, Rosdolsky M et al (2016) Craniopharyngioma adherence: a comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors. NeuroSurg Focus 41:E13","journal-title":"NeuroSurg Focus"},{"key":"5001_CR20","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3171\/jns.2001.94.4.0617","volume":"94","author":"DK Lee","year":"2001","unstructured":"Lee DK, Jung HW, Kim DG et al (2001) Postoperative spinal seeding of craniopharyngioma. Case report. J Neurosurg 94:617\u2013620. https:\/\/doi.org\/10.3171\/jns.2001.94.4.0617","journal-title":"J Neurosurg"},{"key":"5001_CR21","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.3171\/2010.11.JNS10670","volume":"114","author":"P Mortini","year":"2011","unstructured":"Mortini P, Losa M, Pozzobon G et al (2011) Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg 114:1350\u20131359","journal-title":"J Neurosurg"},{"key":"5001_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s11102-016-0751-0","volume":"20","author":"HL M\u00fcller","year":"2017","unstructured":"M\u00fcller HL (2017) Risk-adapted, long-term management in childhood-onset craniopharyngioma. Pituitary 20:267\u2013281","journal-title":"Pituitary"},{"key":"5001_CR23","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1080\/14737175.2018.1528874","volume":"18","author":"A Bogusz","year":"2018","unstructured":"Bogusz A, M\u00fcller HL (2018) Childhood-onset craniopharyngioma: latest insights into pathology, diagnostics, treatment, and follow-up. Expert Rev Neurother 18:793\u2013806","journal-title":"Expert Rev Neurother"},{"key":"5001_CR24","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF01401226","volume":"81","author":"R Sorva","year":"1986","unstructured":"Sorva R, Heiskanen O (1986) Craniopharyngioma in Finland: a study of 123 cases. Acta Neurochir 81:85\u201389","journal-title":"Acta Neurochir"},{"key":"5001_CR25","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3171\/jns.1999.90.2.0237","volume":"90","author":"R Fahlbusch","year":"1999","unstructured":"Fahlbusch R, Honegger J, Paulus W et al (1999) Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 90:237\u2013250","journal-title":"J Neurosurg"},{"key":"5001_CR26","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1210\/jc.2012-3928","volume":"98","author":"E Elowe-Gruau","year":"2013","unstructured":"Elowe-Gruau E, Beltrand J, Brauner R et al (2013) Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity. J Clin Endocrinol Metabolism 98:2376\u20132382","journal-title":"J Clin Endocrinol Metabolism"},{"key":"5001_CR27","first-page":"1029","volume":"17","author":"AS Sterkenburg","year":"2015","unstructured":"Sterkenburg AS, Hoffmann A, Gebhardt U et al (2015) Survival, hypothalamic obesity, and neuropsychological\/psychosocial status after childhood-onset craniopharyngioma: newly reported long-term outcomes. Neurooncology 17:1029\u20131038","journal-title":"Neurooncology"},{"key":"5001_CR28","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1210\/endrev\/bnac035","volume":"44","author":"JR Apps","year":"2023","unstructured":"Apps JR, Muller HL, Hankinson TC et al (2023) Contemporary biological insights and clinical management of craniopharyngioma. Endocr Rev 44:518\u2013538","journal-title":"Endocr Rev"},{"key":"5001_CR29","doi-asserted-by":"publisher","unstructured":"Jannelli G, Calvanese F, Paun L et al (2023) Current advances in papillary craniopharyngioma: State-Of-The-Art therapies and overview of the literature. Brain Sci 13. https:\/\/doi.org\/10.3390\/brainsci13030515","DOI":"10.3390\/brainsci13030515"},{"key":"5001_CR30","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s11102-022-01212-4","volume":"25","author":"P Iglesias","year":"2022","unstructured":"Iglesias P (2022) Targeted therapies in the medical management of craniopharyngioma. Pituitary 25:383\u2013392","journal-title":"Pituitary"},{"key":"5001_CR31","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1056\/NEJMoa2213329","volume":"389","author":"PK Brastianos","year":"2023","unstructured":"Brastianos PK, Twohy E, Geyer S et al (2023) BRAF\u2013MEK Inhibition in newly diagnosed papillary craniopharyngiomas. N Engl J Med 389:118\u2013126","journal-title":"N Engl J Med"},{"key":"5001_CR32","doi-asserted-by":"publisher","first-page":"830793","DOI":"10.3389\/fgene.2022.830793","volume":"13","author":"D Lin","year":"2022","unstructured":"Lin D, Zhao W, Yang J et al (2022) Integrative analysis of biomarkers and mechanisms in adamantinomatous craniopharyngioma. Front Genet 13:830793. https:\/\/doi.org\/10.3389\/fgene.2022.830793","journal-title":"Front Genet"},{"key":"5001_CR33","doi-asserted-by":"publisher","first-page":"859381","DOI":"10.3389\/fendo.2022.859381","volume":"13","author":"C Xu","year":"2022","unstructured":"Xu C, Ge S, Cheng J et al (2022) Pathological and prognostic characterization of craniopharyngioma based on the expression of TrkA, \u03b2-Catenin, cell cycle markers, and BRAF V600E mutation. Front Endocrinol (Lausanne) 13:859381. https:\/\/doi.org\/10.3389\/fendo.2022.859381","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5001_CR34","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1210\/jc.2012-2069","volume":"97","author":"HL M\u00fcller","year":"2012","unstructured":"M\u00fcller HL, Gebhardt U, Faldum A et al (2012) Xanthogranuloma, Rathke\u2019s cyst, and childhood craniopharyngioma: results of prospective multinational studies of children and adolescents with rare Sellar malformations. J Clin Endocrinol Metabolism 97:3935\u20133943","journal-title":"J Clin Endocrinol Metabolism"},{"key":"5001_CR35","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000357783","volume":"49","author":"TC Hankinson","year":"2014","unstructured":"Hankinson TC, Palmeri NO, Williams SA et al (2014) Patterns of care for craniopharyngioma: survey of members of the American association of neurological surgeons. Pediatr NeuroSurg 49:131\u2013136","journal-title":"Pediatr NeuroSurg"},{"key":"5001_CR36","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","volume":"8","author":"D Moher","year":"2010","unstructured":"Moher D, Liberati A, Tetzlaff J et al (2010) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg 8:336\u2013341","journal-title":"Int J Surg"},{"key":"5001_CR37","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"5001_CR38","doi-asserted-by":"publisher","first-page":"217","DOI":"10.3171\/jns.1961.18.2.0217","volume":"18","author":"S Kramer","year":"1961","unstructured":"Kramer S, McKissock W, Concannon JP (1961) Craniopharyngiomas: treatment by combined surgery and radiation therapy. J Neurosurg 18:217\u2013226. https:\/\/doi.org\/10.3171\/jns.1961.18.2.0217","journal-title":"J Neurosurg"},{"key":"5001_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0360-3016(90)90143-8","volume":"19","author":"JC Flickinger","year":"1990","unstructured":"Flickinger JC, Lunsford LD, Singer J et al (1990) Megavoltage external beam irradiation of craniopharyngiomas: analysis of tumor control and morbidity. Int J Radiation Oncology*Biology*Physics 19:117\u2013122. https:\/\/doi.org\/10.1016\/0360-3016(90)90143-8","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"5001_CR40","doi-asserted-by":"publisher","first-page":"44","DOI":"10.2214\/ajr.103.1.44","volume":"103","author":"S KRAMER","year":"1968","unstructured":"KRAMER S, SOUTHARD M, MANSFIELD CM (1968) Radiotherapy in the management of craniopharyngiomas. Am J Roentgenol 103:44\u201352","journal-title":"Am J Roentgenol"},{"key":"5001_CR41","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S0360-3016(02)02799-2","volume":"53","author":"TE Merchant","year":"2002","unstructured":"Merchant TE, Kiehna EN, Sanford RA et al (2002) Craniopharyngioma: the St. Jude children\u2019s research hospital experience 1984\u20132001. Int J Radiation Oncology* Biology* Phys 53:533\u2013542","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"key":"5001_CR42","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.radonc.2005.04.015","volume":"77","author":"LS Pemberton","year":"2005","unstructured":"Pemberton LS, Dougal M, Magee B, Gattamaneni HR (2005) Experience of external beam radiotherapy given adjuvantly or at relapse following surgery for craniopharyngioma. Radiother Oncol 77:99\u2013104. https:\/\/doi.org\/10.1016\/j.radonc.2005.04.015","journal-title":"Radiother Oncol"},{"key":"5001_CR43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0936-6555(05)81101-X","volume":"4","author":"CC Jose","year":"1992","unstructured":"Jose CC, Rajan B, Ashley S et al (1992) Radiotherapy for the treatment of recurrent craniopharyngioma. Clin Oncol 4:287\u2013289. https:\/\/doi.org\/10.1016\/S0936-6555(05)81101-X","journal-title":"Clin Oncol"},{"key":"5001_CR44","unstructured":"Kalapurakal JA, Goldman S, Hsieh YC"},{"key":"5001_CR45","first-page":"388","volume":"6","author":"JA Kalapurakal","year":"2000","unstructured":"Kalapurakal JA, Goldman S, Hsieh YC et al (2000) Clinical outcome in children with recurrent craniopharyngioma after primary surgery. Cancer J 6:388\u2013393","journal-title":"Cancer J"},{"key":"5001_CR46","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s00381-005-1189-2","volume":"21","author":"SH Moon","year":"2005","unstructured":"Moon SH, Kim IH, Park SW et al (2005) Early adjuvant radiotherapy toward long-term survival and better quality of life for craniopharyngiomas\u2014a study in single Institute. Child\u2019s Nerv Syst 21:799\u2013807. https:\/\/doi.org\/10.1007\/s00381-005-1189-2","journal-title":"Child\u2019s Nerv Syst"},{"key":"5001_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0167-8140(93)90019-5","volume":"26","author":"B Rajan","year":"1993","unstructured":"Rajan B, Ashley S, Gorman C et al (1993) Craniopharyngioma \u2014 long-term results following limited surgery and radiotherapy. Radiother Oncol 26:1\u201310. https:\/\/doi.org\/10.1016\/0167-8140(93)90019-5","journal-title":"Radiother Oncol"},{"key":"5001_CR48","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/S0360-3016(03)01570-0","volume":"58","author":"DC Stripp","year":"2004","unstructured":"Stripp DC, Maity A, Janss AJ et al (2004) Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults. Int J Radiation Oncology* Biology* Phys 58:714\u2013720","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"key":"5001_CR49","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0167-8140(93)90039-B","volume":"27","author":"WF Regine","year":"1993","unstructured":"Regine WF, Mohiuddin M, Kramer S (1993) Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation. Radiother Oncol 27:13\u201321. https:\/\/doi.org\/10.1016\/0167-8140(93)90039-B","journal-title":"Radiother Oncol"},{"key":"5001_CR50","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0360-3016(93)90227-M","volume":"27","author":"S Hetelekidis","year":"1993","unstructured":"Hetelekidis S, Barnes PD, Tao ML et al (1993) 20-year experience in childhood craniopharyngioma. Int J Radiation Oncology* Biology* Phys 27:189\u2013195","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"key":"5001_CR51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1148\/radiology.197.1.7568823","volume":"197","author":"RJ Mark","year":"1995","unstructured":"Mark RJ, Lutge WR, Shimizu KT et al (1995) Craniopharyngioma: treatment in the CT and MR imaging era. Radiology 197:195\u2013198. https:\/\/doi.org\/10.1148\/radiology.197.1.7568823","journal-title":"Radiology"},{"key":"5001_CR52","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/s0360-3016(02)02965-6","volume":"54","author":"JM Varlotto","year":"2002","unstructured":"Varlotto JM, Flickinger JC, Kondziolka D et al (2002) External beam irradiation of craniopharyngiomas: long-term analysis of tumor control and morbidity. Int J Radiat Oncol Biol Phys 54:492\u2013499. https:\/\/doi.org\/10.1016\/s0360-3016(02)02965-6","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5001_CR53","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1016\/j.ijrobp.2005.09.034","volume":"64","author":"MM Fitzek","year":"2006","unstructured":"Fitzek MM, Linggood RM, Adams J, Munzenrider JE (2006) Combined proton and photon irradiation for craniopharyngioma: long-term results of the early cohort of patients treated at Harvard cyclotron laboratory and Massachusetts general hospital. Int J Radiat Oncol Biol Phys 64:1348\u20131354. https:\/\/doi.org\/10.1016\/j.ijrobp.2005.09.034","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5001_CR54","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/j.ijrobp.2011.06.076","volume":"81","author":"L Masson-Cote","year":"2011","unstructured":"Masson-Cote L, Masucci G, Atenafu EG et al (2011) Adult craniopharyngioma tumors: Long-term outcomes in patients treated with radiation therapy. Int J Radiat Oncol Biol Phys 81:S37","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5001_CR55","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11060-012-0806-7","volume":"108","author":"A Schoenfeld","year":"2012","unstructured":"Schoenfeld A, Pekmezci M, Barnes MJ et al (2012) The superiority of Conservative resection and adjuvant radiation for craniopharyngiomas. J Neurooncol 108:133\u2013139","journal-title":"J Neurooncol"},{"key":"5001_CR56","doi-asserted-by":"publisher","first-page":"S84","DOI":"10.1016\/j.ijrobp.2021.07.201","volume":"111","author":"D Edmonston","year":"2021","unstructured":"Edmonston D, Wu S, Li Y et al (2021) Limited surgery and conformal photon radiation therapy for pediatric craniopharyngioma: Long-Term results from the RT1 protocol. Int J Radiat Oncol Biol Phys 111:S84. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.07.201","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5001_CR57","doi-asserted-by":"publisher","first-page":"1180993","DOI":"10.3389\/fonc.2023.1180993","volume":"13","author":"C Friedrich","year":"2023","unstructured":"Friedrich C, Boekhoff S, Bischoff M et al (2023) Outcome after proton beam therapy versus photon-based radiation therapy in childhood-onset craniopharyngioma patients-results of KRANIOPHARYNGEOM 2007. Front Oncol 13:1180993. https:\/\/doi.org\/10.3389\/fonc.2023.1180993","journal-title":"Front Oncol"},{"key":"5001_CR58","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/s0360-3016(99)00030-9","volume":"44","author":"JL Habrand","year":"1999","unstructured":"Habrand JL, Ganry O, Couanet D et al (1999) The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int J Radiat Oncol Biol Phys 44:255\u2013263. https:\/\/doi.org\/10.1016\/s0360-3016(99)00030-9","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5001_CR59","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3109\/0284186X.2012.685525","volume":"52","author":"L Masson-Cote","year":"2013","unstructured":"Masson-Cote L, Masucci GL, Atenafu EG et al (2013) Long-term outcomes for adult craniopharyngioma following radiation therapy. Acta Oncol 52:153\u2013158. https:\/\/doi.org\/10.3109\/0284186X.2012.685525","journal-title":"Acta Oncol"},{"key":"5001_CR60","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ijrobp.2014.05.051","volume":"90","author":"AJ Bishop","year":"2014","unstructured":"Bishop AJ, Greenfield B, Mahajan A et al (2014) Proton beam therapy versus conformal photon radiation therapy for childhood craniopharyngioma: multi-institutional analysis of outcomes, cyst dynamics, and toxicity. Int J Radiat Oncol Biol Phys 90:354\u2013361. https:\/\/doi.org\/10.1016\/j.ijrobp.2014.05.051","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5001_CR61","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.radonc.2014.11.035","volume":"114","author":"BJ Greenfield","year":"2015","unstructured":"Greenfield BJ, Okcu MF, Baxter PA et al (2015) Long-term disease control and toxicity outcomes following surgery and intensity modulated radiation therapy (IMRT) in pediatric craniopharyngioma. Radiother Oncol 114:224\u2013229. https:\/\/doi.org\/10.1016\/j.radonc.2014.11.035","journal-title":"Radiother Oncol"},{"key":"5001_CR62","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3171\/2020.11.PEDS20803","volume":"28","author":"VM Ravindra","year":"2021","unstructured":"Ravindra VM, Okcu MF, Ruggieri L et al (2021) Comparison of multimodal surgical and radiation treatment methods for pediatric craniopharyngioma: long-term analysis of progression-free survival and morbidity. J Neurosurg Pediatr 28:152\u2013159. https:\/\/doi.org\/10.3171\/2020.11.PEDS20803","journal-title":"J Neurosurg Pediatr"},{"key":"5001_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-717X-9-193","volume":"9","author":"Y Jeong","year":"2014","unstructured":"Jeong Y, Lee S, Kwak J et al (2014) A dosimetric comparison of volumetric modulated Arc therapy (VMAT) and non-coplanar intensity modulated radiotherapy (IMRT) for nasal cavity and paranasal sinus cancer. Radiat Oncol 9:1\u20139","journal-title":"Radiat Oncol"},{"key":"5001_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-016-0659-x","volume":"11","author":"M Uto","year":"2016","unstructured":"Uto M, Mizowaki T, Ogura K, Hiraoka M (2016) Non-coplanar volumetric-modulated Arc therapy (VMAT) for craniopharyngiomas reduces radiation doses to the bilateral hippocampus: a planning study comparing dynamic conformal Arc therapy, coplanar VMAT, and non-coplanar VMAT. Radiat Oncol 11:1\u20138","journal-title":"Radiat Oncol"},{"key":"5001_CR65","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/PPO.0000000000000079","volume":"20","author":"BR Eaton","year":"2014","unstructured":"Eaton BR, Yock T (2014) The use of proton therapy in the treatment of benign or low-grade pediatric brain tumors. Cancer J 20:403\u2013408","journal-title":"Cancer J"},{"key":"5001_CR66","first-page":"155","volume":"12","author":"QT Luu","year":"2006","unstructured":"Luu QT, Loredo LN, Archambeau JO et al (2006) Fractionated proton radiation treatment for pediatric craniopharyngioma: preliminary report. Cancer J 12:155\u2013159","journal-title":"Cancer J"},{"key":"5001_CR67","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1002\/pbc.22884","volume":"56","author":"KM Winkfield","year":"2011","unstructured":"Winkfield KM, Tsai HK, Yao X et al (2011) Long-term clinical outcomes following treatment of childhood craniopharyngioma. Pediatr Blood Cancer 56:1120\u20131126. https:\/\/doi.org\/10.1002\/pbc.22884","journal-title":"Pediatr Blood Cancer"},{"key":"5001_CR68","doi-asserted-by":"publisher","unstructured":"Indelicato DJ, Bradley JA, Sandler ES et al (2017) Clinical outcomes following proton therapy for children with central nervous system tumors referred overseas. Pediatr Blood Cancer 64. https:\/\/doi.org\/10.1002\/pbc.26654","DOI":"10.1002\/pbc.26654"},{"key":"5001_CR69","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11060-020-03432-9","volume":"147","author":"MS Rutenberg","year":"2020","unstructured":"Rutenberg MS, Rotondo RL, Rao D et al (2020) Clinical outcomes following proton therapy for adult craniopharyngioma: a single-institution cohort study. J Neurooncol 147:387\u2013395. https:\/\/doi.org\/10.1007\/s11060-020-03432-9","journal-title":"J Neurooncol"},{"key":"5001_CR70","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1016\/j.ijrobp.2021.02.045","volume":"110","author":"RB Jimenez","year":"2021","unstructured":"Jimenez RB, Ahmed S, Johnson A et al (2021) Proton radiation therapy for pediatric craniopharyngioma. Int J Radiation Oncology* Biology* Phys 110:1480\u20131487","journal-title":"Int J Radiation Oncology* Biology* Phys"},{"key":"5001_CR71","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1093\/neuonc\/noac210","volume":"25","author":"A Beddok","year":"2023","unstructured":"Beddok A, Scher N, Alapetite C et al (2023) Proton therapy for adult craniopharyngioma: experience of a single institution in 91 consecutive patients. Neuro Oncol 25:710\u2013719. https:\/\/doi.org\/10.1093\/neuonc\/noac210","journal-title":"Neuro Oncol"},{"key":"5001_CR72","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S1470-2045(23)00146-8","volume":"24","author":"T Merchant","year":"2023","unstructured":"Merchant T, Hoehn M, Khan R et al (2023) Proton therapy and limited surgery for paediatric and adolescent patients with craniopharyngioma (RT2CR) a single arm, phase 2 study. LANCET Oncol 24:523\u2013534. https:\/\/doi.org\/10.1016\/S1470-2045(23)00146-8","journal-title":"LANCET Oncol"},{"key":"5001_CR73","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijrobp.2024.03.015","volume":"120","author":"M Bischoff","year":"2024","unstructured":"Bischoff M, Khalil DA, Frisch S et al (2024) Outcome after modern proton beam therapy in childhood craniopharyngioma: results of the prospective registry study KiProReg. Int J Radiat Oncol Biol Phys 120:137\u2013148. https:\/\/doi.org\/10.1016\/j.ijrobp.2024.03.015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5001_CR74","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ijrobp.2010.11.027","volume":"82","author":"NS Boehling","year":"2012","unstructured":"Boehling NS, Grosshans DR, Bluett JB et al (2012) Dosimetric comparison of Three-Dimensional conformal proton radiotherapy, Intensity-Modulated proton therapy, and Intensity-Modulated radiotherapy for treatment of pediatric craniopharyngiomas. Int J Radiation Oncology*Biology*Physics 82:643\u2013652. https:\/\/doi.org\/10.1016\/j.ijrobp.2010.11.027","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"5001_CR75","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.radonc.2019.08.002","volume":"142","author":"L Toussaint","year":"2020","unstructured":"Toussaint L, Indelicato DJ, Muren LP et al (2020) Temporal lobe sparing radiotherapy with photons or protons for cognitive function preservation in paediatric craniopharyngioma. Radiother Oncol 142:140\u2013146. https:\/\/doi.org\/10.1016\/j.radonc.2019.08.002","journal-title":"Radiother Oncol"},{"key":"5001_CR76","doi-asserted-by":"publisher","first-page":"e407","DOI":"10.1016\/j.wneu.2024.02.039","volume":"185","author":"N Burela","year":"2024","unstructured":"Burela N, Das A, Krishnan G et al (2024) Encouraging experience with Image-Guided pencil beam scanning proton therapy in Craniopharyngioma\u2014First case series from India. World Neurosurg 185:e407\u2013e414. https:\/\/doi.org\/10.1016\/j.wneu.2024.02.039","journal-title":"World Neurosurg"},{"key":"5001_CR77","doi-asserted-by":"publisher","first-page":"e281","DOI":"10.1016\/j.ijrobp.2011.01.005","volume":"82","author":"C Beltran","year":"2012","unstructured":"Beltran C, Roca M, Merchant TE (2012) On the benefits and risks of proton therapy in pediatric craniopharyngioma. Int J Radiation Oncology*Biology*Physics 82:e281\u2013e287. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.01.005","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"5001_CR78","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s11060-011-0693-3","volume":"106","author":"H Iwata","year":"2012","unstructured":"Iwata H, Tatewaki K, Inoue M et al (2012) Single and hypofractionated stereotactic radiotherapy with cyberknife for craniopharyngioma. J Neurooncol 106:571\u2013577. https:\/\/doi.org\/10.1007\/s11060-011-0693-3","journal-title":"J Neurooncol"},{"key":"5001_CR79","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.ygyno.2007.11.027","volume":"108","author":"Y-K Lee","year":"2008","unstructured":"Lee Y-K, Park N-H, Kim JW et al (2008) Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer. Gynecol Oncol 108:505\u2013509","journal-title":"Gynecol Oncol"},{"key":"5001_CR80","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/0284186X.2016.1270466","volume":"56","author":"A Astradsson","year":"2017","unstructured":"Astradsson A, Munck Af Rosensch\u00f6ld P, Feldt-Rasmussen U et al (2017) Visual outcome, endocrine function and tumor control after fractionated stereotactic radiation therapy of craniopharyngiomas in adults: findings in a prospective cohort. Acta Oncol 56:415\u2013421. https:\/\/doi.org\/10.1080\/0284186X.2016.1270466","journal-title":"Acta Oncol"},{"key":"5001_CR81","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1177\/153303460200100107","volume":"1","author":"MT Selch","year":"2002","unstructured":"Selch MT, DeSalles AAF, Wade M et al (2002) Initial clinical results of stereotactic radiotherapy for the treatment of craniopharyngiomas. Technol Cancer Res Treat 1:51\u201359. https:\/\/doi.org\/10.1177\/153303460200100107","journal-title":"Technol Cancer Res Treat"},{"key":"5001_CR82","doi-asserted-by":"publisher","first-page":"2308","DOI":"10.1002\/cncr.22703","volume":"109","author":"SE Combs","year":"2007","unstructured":"Combs SE, Thilmann C, Huber PE et al (2007) Achievement of long-term local control in patients with craniopharyngiomas using high precision stereotactic radiotherapy. Cancer 109:2308\u20132314. https:\/\/doi.org\/10.1002\/cncr.22703","journal-title":"Cancer"},{"key":"5001_CR83","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.radonc.2006.11.005","volume":"82","author":"G Minniti","year":"2007","unstructured":"Minniti G, Saran F, Traish D et al (2007) Fractionated stereotactic conformal radiotherapy following Conservative surgery in the control of craniopharyngiomas. Radiother Oncol 82:90\u201395. https:\/\/doi.org\/10.1016\/j.radonc.2006.11.005","journal-title":"Radiother Oncol"},{"key":"5001_CR84","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1016\/j.ijrobp.2011.05.014","volume":"82","author":"N Kanesaka","year":"2012","unstructured":"Kanesaka N, Mikami R, Nakayama H et al (2012) Preliminary results of fractionated stereotactic radiotherapy after cyst drainage for craniopharyngioma in adults. Int J Radiat Oncol Biol Phys 82:1356\u20131360. https:\/\/doi.org\/10.1016\/j.ijrobp.2011.05.014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5001_CR85","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/1748-717X-9-203","volume":"9","author":"SB Harrabi","year":"2014","unstructured":"Harrabi SB, Adeberg S, Welzel T et al (2014) Long term results after fractionated stereotactic radiotherapy (FSRT) in patients with craniopharyngioma: maximal tumor control with minimal side effects. Radiat Oncol 9:203. https:\/\/doi.org\/10.1186\/1748-717X-9-203","journal-title":"Radiat Oncol"},{"key":"5001_CR86","doi-asserted-by":"publisher","first-page":"611","DOI":"10.3171\/2017.4.JNS162143","volume":"129","author":"Y-S Dho","year":"2018","unstructured":"Dho Y-S, Kim YH, Se Y-B et al (2018) Endoscopic endonasal approach for craniopharyngioma: the importance of the relationship between pituitary stalk and tumor. J Neurosurg 129:611\u2013619. https:\/\/doi.org\/10.3171\/2017.4.JNS162143","journal-title":"J Neurosurg"},{"key":"5001_CR87","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s11102-018-0903-5","volume":"21","author":"M Losa","year":"2018","unstructured":"Losa M, Pieri V, Bailo M et al (2018) Single fraction and multisession gamma knife radiosurgery for craniopharyngioma. Pituitary 21:499\u2013506. https:\/\/doi.org\/10.1007\/s11102-018-0903-5","journal-title":"Pituitary"},{"key":"5001_CR88","doi-asserted-by":"publisher","unstructured":"Poiset SJ, Song A et al (2024) In Yoon H, Long-Term Outcomes of Surgery and Radiation Treatment for Adult Patients with Craniopharyngioma. World Neurosurg 187:e852\u2013e859. https:\/\/doi.org\/10.1016\/j.wneu.2024.04.177","DOI":"10.1016\/j.wneu.2024.04.177"},{"key":"5001_CR89","doi-asserted-by":"publisher","unstructured":"Mokry M (1999) Craniopharyngiomas: A six year experience with gamma knife radiosurgery. Stereotact Funct Neurosurg 72 Suppl 1140\u2013149. https:\/\/doi.org\/10.1159\/000056450","DOI":"10.1159\/000056450"},{"key":"5001_CR90","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3171\/jns.2000.93.supplement_3.0047","volume":"93","author":"W-Y Chung","year":"2000","unstructured":"Chung W-Y, Pan DH-C, Shiau C-Y et al (2000) Gamma knife radiosurgery for craniopharyngiomas. J Neurosurg 93:47\u201356. https:\/\/doi.org\/10.3171\/jns.2000.93.supplement_3.0047","journal-title":"J Neurosurg"},{"key":"5001_CR91","first-page":"159","volume":"3","author":"S-M Chiou","year":"2001","unstructured":"Chiou S-M, Lunsford LD, Niranjan A et al (2001) Stereotactic radiosurgery of residual or recurrent craniopharyngioma, after surgery, with or without radiation therapy. Neurooncology 3:159\u2013166","journal-title":"Neurooncology"},{"key":"5001_CR92","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3171\/jns.2002.97.supplement","volume":"97","author":"E Ulfarsson","year":"2002","unstructured":"Ulfarsson E, Lindquist C, Roberts M et al (2002) Gamma knife radiosurgery for craniopharyngiomas: long-term results in the first Swedish patients. J Neurosurg 97:613\u2013622. https:\/\/doi.org\/10.3171\/jns.2002.97.supplement","journal-title":"J Neurosurg"},{"key":"5001_CR93","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1002\/mpo.10364","volume":"41","author":"BE Amendola","year":"2003","unstructured":"Amendola BE, Wolf A, Coy SR, Amendola MA (2003) Role of radiosurgery in craniopharyngiomas: a preliminary report. Med Pediatr Oncol 41:123\u2013127","journal-title":"Med Pediatr Oncol"},{"key":"5001_CR94","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3171\/ped.2005.103.6.0482","volume":"103","author":"T Kobayashi","year":"2005","unstructured":"Kobayashi T, Kida Y, Mori Y, Hasegawa T (2005) Long-term results of gamma knife surgery for the treatment of craniopharyngioma in 98 consecutive cases. J Neurosurgery: Pediatr 103:482\u2013488. https:\/\/doi.org\/10.3171\/ped.2005.103.6.0482","journal-title":"J Neurosurgery: Pediatr"},{"key":"5001_CR95","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1159\/000236370","volume":"87","author":"S Yomo","year":"2009","unstructured":"Yomo S, Hayashi M, Chernov M et al (2009) Stereotactic radiosurgery of residual or recurrent craniopharyngioma: new treatment concept using Leksell gamma knife model C with automatic positioning system. Stereotact Funct Neurosurg 87:360\u2013367. https:\/\/doi.org\/10.1159\/000236370","journal-title":"Stereotact Funct Neurosurg"},{"key":"5001_CR96","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s11060-010-0494-0","volume":"104","author":"Z Xu","year":"2011","unstructured":"Xu Z, Yen C-P, Schlesinger D, Sheehan J (2011) Outcomes of gamma knife surgery for craniopharyngiomas. J Neurooncol 104:305\u2013313. https:\/\/doi.org\/10.1007\/s11060-010-0494-0","journal-title":"J Neurooncol"},{"key":"5001_CR97","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3171\/2014.8.GKS141411","volume":"121","author":"C-C Lee","year":"2014","unstructured":"Lee C-C, Yang H-C, Chen C-J et al (2014) Gamma knife surgery for craniopharyngioma: report on a 20-year experience: clinical Article. J Neurosurg JNS 121:167\u2013178. https:\/\/doi.org\/10.3171\/2014.8.GKS141411","journal-title":"J Neurosurg JNS"},{"key":"5001_CR98","first-page":"447","volume":"77","author":"T Kobayashi","year":"2015","unstructured":"Kobayashi T, Tsugawa T, Hatano M et al (2015) Gamma knife radiosurgery of craniopharyngioma: results of 30 cases treated at Nagoya radiosurgery center. Nagoya J Med Sci 77:447\u2013454","journal-title":"Nagoya J Med Sci"},{"key":"5001_CR99","doi-asserted-by":"publisher","first-page":"e6973","DOI":"10.7759\/cureus.6973","volume":"12","author":"T Tsugawa","year":"2020","unstructured":"Tsugawa T, Kobayashi T, Hasegawa T et al (2020) Gamma knife surgery for residual or recurrent craniopharyngioma after surgical resection: A Multi-institutional retrospective study in Japan. Cureus 12:e6973. https:\/\/doi.org\/10.7759\/cureus.6973","journal-title":"Cureus"},{"key":"5001_CR100","doi-asserted-by":"publisher","first-page":"3201","DOI":"10.1007\/s00701-021-04990-1","volume":"163","author":"S Pikis","year":"2021","unstructured":"Pikis S, Mantziaris G, Lavezzo K et al (2021) Stereotactic radiosurgery for craniopharyngiomas. Acta Neurochir 163:3201\u20133207. https:\/\/doi.org\/10.1007\/s00701-021-04990-1","journal-title":"Acta Neurochir"},{"key":"5001_CR101","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s11060-021-03806-7","volume":"154","author":"A Ogino","year":"2021","unstructured":"Ogino A, Niranjan A, Kano H et al (2021) Optimizing stereotactic radiosurgery in patients with recurrent or residual craniopharyngiomas. J Neurooncol 154:113\u2013120. https:\/\/doi.org\/10.1007\/s11060-021-03806-7","journal-title":"J Neurooncol"},{"key":"5001_CR102","doi-asserted-by":"publisher","first-page":"100327","DOI":"10.1016\/j.wnsx.2024.100327","volume":"22","author":"S Gupta","year":"2024","unstructured":"Gupta S, Agrawal D, Kedia S, Kale SS (2024) Should post-operative stereotactic radiosurgery be the standard of care in craniopharyngioma patients? World Neurosurgery: X 22:100327. https:\/\/doi.org\/10.1016\/j.wnsx.2024.100327","journal-title":"World Neurosurgery: X"},{"key":"5001_CR103","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3340\/jkns.2008.44.2.67","volume":"44","author":"J-W Kim","year":"2008","unstructured":"Kim J-W, Im Y-S, Nam D-H et al (2008) Preliminary report of multisession gamma knife radiosurgery for benign perioptic lesions: visual outcome in 22 patients. J Korean Neurosurg Soc 44:67\u201371. https:\/\/doi.org\/10.3340\/jkns.2008.44.2.67","journal-title":"J Korean Neurosurg Soc"},{"key":"5001_CR104","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1227\/01.NEU.0000223512.09115.3E","volume":"59","author":"JRJ Adler","year":"2006","unstructured":"Adler JRJ, Gibbs IC, Puataweepong P, Chang SD (2006) Visual field preservation after multisession cyberknife radiosurgery for perioptic lesions. Neurosurgery 59:244\u2013254 discussion 244\u2013254. https:\/\/doi.org\/10.1227\/01.NEU.0000223512.09115.3E","journal-title":"Neurosurgery"},{"key":"5001_CR105","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3171\/jns.1998.88.1.0043","volume":"88","author":"KA Leber","year":"1998","unstructured":"Leber KA, Bergl\u00f6ff J, Pendl G (1998) Dose\u2014response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 88:43\u201350. https:\/\/doi.org\/10.3171\/jns.1998.88.1.0043","journal-title":"J Neurosurg"},{"key":"5001_CR106","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1016\/S0360-3016(02)04380-8","volume":"55","author":"SL Stafford","year":"2003","unstructured":"Stafford SL, Pollock BE, Leavitt JA et al (2003) A study on the radiation tolerance of the optic nerves and Chiasm after stereotactic radiosurgery. Int J Radiation Oncology*Biology*Physics 55:1177\u20131181. https:\/\/doi.org\/10.1016\/S0360-3016(02)04380-8","journal-title":"Int J Radiation Oncology*Biology*Physics"},{"key":"5001_CR107","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1007\/s11060-018-2943-0","volume":"140","author":"Y-S Dho","year":"2018","unstructured":"Dho Y-S, Kim YH, Kim JW et al (2018) Optimal strategy of gamma knife radiosurgery for craniopharyngiomas. J Neurooncol 140:135\u2013143. https:\/\/doi.org\/10.1007\/s11060-018-2943-0","journal-title":"J Neurooncol"},{"key":"5001_CR108","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/0360-3016(95)00175-X","volume":"33","author":"BE Pollock","year":"1995","unstructured":"Pollock BE, Lunsford LD, Kondziolka D et al (1995) Phosphorus-32 intracavitary irradiation of cystic craniopharyngiomas: current technique and long-term results. INT J RADIAT ONCOL BIOL PHYS 33:437\u2013446. https:\/\/doi.org\/10.1016\/0360-3016(95)00175-X","journal-title":"INT J RADIAT ONCOL BIOL PHYS"},{"key":"5001_CR109","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s00381-005-1185-6","volume":"21","author":"AL Albright","year":"2005","unstructured":"Albright AL, Hadjipanayis CG, Lunsford LD et al (2005) Individualized treatment of pediatric craniopharyngiomas. Childs Nerv Syst 21:649\u2013654. https:\/\/doi.org\/10.1007\/s00381-005-1185-6","journal-title":"Childs Nerv Syst"},{"key":"5001_CR110","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.radonc.2010.12.001","volume":"98","author":"RB Barriger","year":"2011","unstructured":"Barriger RB, Chang A, Lo SS et al (2011) Phosphorus-32 therapy for cystic craniopharyngiomas. Radiother Oncol 98:207\u2013212. https:\/\/doi.org\/10.1016\/j.radonc.2010.12.001","journal-title":"Radiother Oncol"},{"key":"5001_CR111","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00066-015-0910-7","volume":"192","author":"M Maarouf","year":"2016","unstructured":"Maarouf M, El Majdoub F, Fuetsch M et al (2016) Stereotactic intracavitary brachytherapy with P-32 for cystic craniopharyngiomas in children. Strahlenther Onkol 192:157\u2013165. https:\/\/doi.org\/10.1007\/s00066-015-0910-7","journal-title":"Strahlenther Onkol"},{"key":"5001_CR112","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.ijrobp.2021.05.123","volume":"111","author":"X Yu","year":"2021","unstructured":"Yu X, Christ SM, Liu R et al (2021) Evaluation of Long-Term outcomes and toxicity after stereotactic Phosphorus-32-Based intracavitary brachytherapy in patients with cystic craniopharyngioma. Int J Radiat Oncol Biol Phys 111:773\u2013784. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.05.123","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"5001_CR113","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s11060-012-0902-8","volume":"109","author":"P Kickingereder","year":"2012","unstructured":"Kickingereder P, Maarouf M, El Majdoub F et al (2012) Intracavitary brachytherapy using stereotactically applied phosphorus-32 colloid for treatment of cystic craniopharyngiomas in 53 patients. J Neuro-Oncol 109:365\u2013374. https:\/\/doi.org\/10.1007\/s11060-012-0902-8","journal-title":"J Neuro-Oncol"},{"key":"5001_CR114","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1097\/00006123-199702000-00006","volume":"40","author":"J Voges","year":"1997","unstructured":"Voges J, Sturm V, Lehrke R et al (1997) Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources. Neurosurgery 40:263\u2013269 discussion 269\u2013270. https:\/\/doi.org\/10.1097\/00006123-199702000-00006","journal-title":"Neurosurgery"},{"key":"5001_CR115","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11102-012-0442-4","volume":"16","author":"JV Julow","year":"2013","unstructured":"Julow JV (2013) Intracystic irradiation for craniopharyngiomas. Pituitary 16:34\u201345. https:\/\/doi.org\/10.1007\/s11102-012-0442-4","journal-title":"Pituitary"},{"key":"5001_CR116","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1227\/01.NEU.0000335786.10968.2F","volume":"63","author":"S Derrey","year":"2008","unstructured":"Derrey S, Blond S, Reyns N et al (2008) MANAGEMENT OF CYSTIC CRANIOPHARYNGIOMAS WITH STEREOTACTIC ENDOCAVITARY IRRADIATION USING COLLOIDAL 186: A RETROSPECTIVE STUDY OF 48 CONSECUTIVE PATIENTS. Neurosurgery 63:1045\u20131053","journal-title":"Neurosurgery"},{"key":"5001_CR117","doi-asserted-by":"publisher","first-page":"545","DOI":"10.3171\/jns.1992.77.4.0545","volume":"77","author":"JH van den Berge","year":"1992","unstructured":"van den Berge JH, Blaauw G, Breeman WAP et al (1992) Intracavitary brachytherapy of cystic craniopharyngiomas. J Neurosurg 77:545\u2013550. https:\/\/doi.org\/10.3171\/jns.1992.77.4.0545","journal-title":"J Neurosurg"},{"key":"5001_CR118","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1227\/01.neu.0000114262.30035.af","volume":"54","author":"T Hasegawa","year":"2004","unstructured":"Hasegawa T, Kondziolka D, Hadjipanayis CG, Lunsford LD (2004) Management of cystic craniopharyngiomas with phosphorus-32 intracavitary irradiation. Neurosurgery 54:813\u2013820 discussion 820\u2013822. https:\/\/doi.org\/10.1227\/01.neu.0000114262.30035.af","journal-title":"Neurosurgery"},{"key":"5001_CR119","doi-asserted-by":"publisher","unstructured":"Adeberg S, Harrabi SB, Bougatf N et al (2018) Dosimetric comparison of proton radiation therapy, volumetric modulated Arc therapy, and Three-Dimensional conformal radiotherapy based on intracranial tumor location. Cancers (Basel) 10. https:\/\/doi.org\/10.3390\/cancers10110401","DOI":"10.3390\/cancers10110401"},{"key":"5001_CR120","doi-asserted-by":"publisher","first-page":"e876","DOI":"10.1016\/j.wneu.2023.04.037","volume":"175","author":"KL Webb","year":"2023","unstructured":"Webb KL, Pruter WW, Hinkle ML, Walsh MT (2023) Comparing surgical approaches for craniopharyngioma resection among adults and children: a meta-analysis and systematic review. World Neurosurg 175:e876\u2013e896","journal-title":"World Neurosurg"},{"key":"5001_CR121","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s003810050272","volume":"14","author":"PG Fisher","year":"1998","unstructured":"Fisher PG, Jenab J, Goldthwaite PT et al (1998) Outcomes and failure patterns in childhood craniopharyngiomas. Child\u2019s Nerv Syst 14:558\u2013563","journal-title":"Child\u2019s Nerv Syst"},{"key":"5001_CR122","doi-asserted-by":"publisher","first-page":"224","DOI":"10.3171\/jns.2005.103.2.0224","volume":"103","author":"Y Minamida","year":"2005","unstructured":"Minamida Y, Mikami T, Hashi K, Houkin K (2005) Surgical management of the recurrence and regrowth of craniopharyngiomas. J Neurosurg 103:224\u2013232","journal-title":"J Neurosurg"},{"key":"5001_CR123","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00381-007-0456-9","volume":"24","author":"M Vinchon","year":"2008","unstructured":"Vinchon M, Dhellemmes P (2008) Craniopharyngiomas in children: recurrence, reoperation and outcome. Child\u2019s Nerv Syst 24:211\u2013217","journal-title":"Child\u2019s Nerv Syst"},{"key":"5001_CR124","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3171\/jns.1996.85.1.0073","volume":"85","author":"CJ De Vile","year":"1996","unstructured":"De Vile CJ, Grant DB, Kendall BE et al (1996) Management of childhood craniopharyngioma: can the morbidity of radical surgery be predicted? J Neurosurg 85:73\u201381","journal-title":"J Neurosurg"},{"key":"5001_CR125","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1007\/s00381-022-05635-z","volume":"38","author":"S Sarkar","year":"2022","unstructured":"Sarkar S, Korula S, Mathai S et al (2022) Upfront adjuvant irradiation versus postoperative surveillance following incomplete surgical resection of craniopharyngiomas in children and young adults. Childs Nerv Syst 38:1877\u20131883. https:\/\/doi.org\/10.1007\/s00381-022-05635-z","journal-title":"Childs Nerv Syst"},{"key":"5001_CR126","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1111\/j.1365-2265.2005.02231.x","volume":"62","author":"N Karavitaki","year":"2005","unstructured":"Karavitaki N, Brufani C, Warner J et al (2005) Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow\u2010up. Clin Endocrinol 62:397\u2013409","journal-title":"Clin Endocrinol"},{"key":"5001_CR127","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3171\/jns.1990.73.1.0003","volume":"73","author":"MG Ya\u015fargil","year":"1990","unstructured":"Ya\u015fargil MG, Curcic M, Kis M et al (1990) Total removal of craniopharyngiomas: approaches and long-term results in 144 patients. J Neurosurg 73:3\u201311","journal-title":"J Neurosurg"},{"key":"5001_CR128","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.adro.2020.07.020","volume":"5","author":"SJ Foran","year":"2020","unstructured":"Foran SJ, Laperriere N, Edelstein K et al (2020) Reirradiation for recurrent craniopharyngioma. Adv Radiation Oncol 5:1305\u20131310","journal-title":"Adv Radiation Oncol"},{"key":"5001_CR129","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1016\/j.radcr.2020.07.015","volume":"15","author":"L Burgess","year":"2020","unstructured":"Burgess L, Chakraborty S, Malone S (2020) Effective salvage of recurrent craniopharyngioma with fractionated stereotactic radiotherapy. Radiol Case Rep 15:1750\u20131755. https:\/\/doi.org\/10.1016\/j.radcr.2020.07.015","journal-title":"Radiol Case Rep"},{"key":"5001_CR130","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/S2213-8587(22)00160-7","volume":"10","author":"R Hamblin","year":"2022","unstructured":"Hamblin R, Vardon A, Akpalu J et al (2022) Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillance. Lancet Diabetes Endocrinol 10:581\u2013588. https:\/\/doi.org\/10.1016\/S2213-8587(22)00160-7","journal-title":"Lancet Diabetes Endocrinol"},{"key":"5001_CR131","first-page":"i16","volume":"24","author":"F Chien","year":"2022","unstructured":"Chien F, Schniederjan M, Castellino RC et al (2022) RARE-31. Radiation induced malignancy associated with pediatric craniopharyngioma: a single institution experience. Neurooncology 24:i16\u2013i17","journal-title":"Neurooncology"},{"key":"5001_CR132","doi-asserted-by":"crossref","unstructured":"Young M, Delaney A, Jurbergs N et al (2022) Radiotherapy alone for pediatric patients with craniopharyngioma. J Neurooncol 1\u201310","DOI":"10.1007\/s11060-021-03908-2"},{"key":"5001_CR133","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/COC.0000000000000378","volume":"41","author":"C Zhang","year":"2018","unstructured":"Zhang C, Verma V, Lyden ER et al (2018) The role of definitive radiotherapy in craniopharyngioma: a SEER analysis. Am J Clin Oncol 41:807\u2013812","journal-title":"Am J Clin Oncol"},{"key":"5001_CR134","first-page":"516","volume":"7","author":"M Isaac","year":"2001","unstructured":"Isaac M, Hahn S, Kim J et al (2001) Management of craniopharyngioma. Cancer J 7:516\u2013520","journal-title":"Cancer J"},{"key":"5001_CR135","doi-asserted-by":"publisher","first-page":"djv310","DOI":"10.1093\/jnci\/djv310","volume":"108","author":"PK Brastianos","year":"2016","unstructured":"Brastianos PK, Shankar GM, Gill CM et al (2016) Dramatic response of BRAF V600E mutant papillary craniopharyngioma to targeted therapy. J Natl Cancer Inst 108:djv310","journal-title":"J Natl Cancer Inst"},{"key":"5001_CR136","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1007\/s00701-017-3311-0","volume":"159","author":"E Rostami","year":"2017","unstructured":"Rostami E, Witt Nystr\u00f6m P, Libard S et al (2017) Recurrent papillary craniopharyngioma with BRAFV600E mutation treated with neoadjuvant-targeted therapy. Acta Neurochir 159:2217\u20132221","journal-title":"Acta Neurochir"},{"key":"5001_CR137","doi-asserted-by":"publisher","first-page":"95","DOI":"10.2217\/cns-2016-0034","volume":"6","author":"A Roque","year":"2017","unstructured":"Roque A, Odia Y (2017) BRAF-V600E mutant papillary craniopharyngioma dramatically responds to combination BRAF and MEK inhibitors. CNS Oncol 6:95\u201399","journal-title":"CNS Oncol"},{"key":"5001_CR138","doi-asserted-by":"publisher","first-page":"2910","DOI":"10.1002\/cncr.32197","volume":"125","author":"TA Juratli","year":"2019","unstructured":"Juratli TA, Jones PS, Wang N et al (2019) Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations. Cancer 125:2910\u20132914","journal-title":"Cancer"},{"key":"5001_CR139","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3171\/2017.11.JNS172373","volume":"130","author":"BT Himes","year":"2018","unstructured":"Himes BT, Ruff MW, Van Gompel JJ et al (2018) Recurrent papillary craniopharyngioma with BRAF V600E mutation treated with Dabrafenib: case report. J Neurosurg 130:1299\u20131303","journal-title":"J Neurosurg"},{"key":"5001_CR140","first-page":"0","volume":"26","author":"K Dorris","year":"2024","unstructured":"Dorris K, Mettetal A, Hemenway M et al (2024) CP-12. PHASE 0 AND FEASIBILITY SINGLE-INSTITUTION CLINICAL TRIAL OF INTRAVENOUS TOCILIZUMAB FOR ADAMANTINOMATOUS CRANIOPHARYNGIOMA. Neurooncology 26:0","journal-title":"Neurooncology"},{"key":"5001_CR141","unstructured":"ClinicalTrials.gov Identifier (2024) NCT05233397. Tocilizumab for the treatment of progressive or recurrent pediatric adamantinomatous craniopharyngioma. Retrieved September"},{"key":"5001_CR142","doi-asserted-by":"publisher","first-page":"5537","DOI":"10.1158\/1078-0432.CCR-13-3003","volume":"20","author":"G Chen","year":"2014","unstructured":"Chen G, Chakravarti N, Aardalen K et al (2014) Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target. Clin Cancer Res 20:5537\u20135546","journal-title":"Clin Cancer Res"},{"key":"5001_CR143","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/s41588-020-0592-7","volume":"52","author":"DJH Shih","year":"2020","unstructured":"Shih DJH, Nayyar N, Bihun I et al (2020) Genomic characterization of human brain metastases identifies drivers of metastatic lung adenocarcinoma. Nat Genet 52:371\u2013377. https:\/\/doi.org\/10.1038\/s41588-020-0592-7","journal-title":"Nat Genet"},{"key":"5001_CR144","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","volume":"155","author":"CW Brennan","year":"2013","unstructured":"Brennan CW, Verhaak RG, McKenna A et al (2013) The somatic genomic landscape of glioblastoma. Cell 155:462\u2013477","journal-title":"Cell"},{"key":"5001_CR145","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/ng.3457","volume":"48","author":"H Bai","year":"2016","unstructured":"Bai H, Harmanc\u0131 AS, Erson-Omay EZ et al (2016) Integrated genomic characterization of IDH1-mutant glioma malignant progression. Nat Genet 48:59\u201366","journal-title":"Nat Genet"},{"key":"5001_CR146","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03167-4","author":"JZ Wang","year":"2024","unstructured":"Wang JZ, Patil V, Landry AP et al (2024) Molecular classification to refine surgical and radiotherapeutic decision-making in meningioma. Nat Med. https:\/\/doi.org\/10.1038\/s41591-024-03167-4","journal-title":"Nat Med"},{"key":"5001_CR147","doi-asserted-by":"publisher","first-page":"CASE24387","DOI":"10.3171\/CASE24387","volume":"8","author":"PM Harary","year":"2024","unstructured":"Harary PM, Hori YS, Persad ARL et al (2024) KEAP1-mutant atypical meningioma: illustrative case. J Neurosurgery: Case Lessons 8:CASE24387. https:\/\/doi.org\/10.3171\/CASE24387","journal-title":"J Neurosurgery: Case Lessons"},{"key":"5001_CR148","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s11060-022-04221-2","volume":"161","author":"AP Landry","year":"2023","unstructured":"Landry AP, Wang JZ, Suppiah S, Zadeh G (2023) Multiplatform molecular analysis of vestibular Schwannoma reveals two robust subgroups with distinct microenvironment. J Neurooncol 161:491\u2013499. https:\/\/doi.org\/10.1007\/s11060-022-04221-2","journal-title":"J Neurooncol"},{"key":"5001_CR149","doi-asserted-by":"publisher","first-page":"3682","DOI":"10.3390\/cancers13153682","volume":"13","author":"R Tonse","year":"2021","unstructured":"Tonse R, Tom MC, Mehta MP et al (2021) Integration of systemic therapy and stereotactic radiosurgery for brain metastases. Cancers 13:3682","journal-title":"Cancers"},{"key":"5001_CR150","doi-asserted-by":"publisher","first-page":"752119","DOI":"10.3389\/fneur.2021.752119","volume":"12","author":"C Qin","year":"2021","unstructured":"Qin C, Hu W, Wang X, Ma X (2021) Application of artificial intelligence in diagnosis of craniopharyngioma. Front Neurol 12:752119. https:\/\/doi.org\/10.3389\/fneur.2021.752119","journal-title":"Front Neurol"},{"key":"5001_CR151","doi-asserted-by":"publisher","first-page":"16885","DOI":"10.1038\/s41598-020-73278-8","volume":"10","author":"EW Prince","year":"2020","unstructured":"Prince EW, Whelan R, Mirsky DM et al (2020) Robust deep learning classification of adamantinomatous craniopharyngioma from limited preoperative radiographic images. Sci Rep 10:16885. https:\/\/doi.org\/10.1038\/s41598-020-73278-8","journal-title":"Sci Rep"},{"key":"5001_CR152","doi-asserted-by":"publisher","first-page":"510","DOI":"10.3171\/2014.10.PEDS14302","volume":"15","author":"X Yu","year":"2015","unstructured":"Yu X, Zhang J, Liu R et al (2015) Interstitial radiotherapy using phosphorus-32 for giant posterior fossa cystic craniopharyngiomas. J Neurosurg Pediatr 15:510\u2013518. https:\/\/doi.org\/10.3171\/2014.10.PEDS14302","journal-title":"J Neurosurg Pediatr"},{"key":"5001_CR153","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3171\/jns.2000.92.2.0255","volume":"92","author":"RI Jakacki","year":"2000","unstructured":"Jakacki RI, Cohen BH, Jamison C et al (2000) Phase II evaluation of interferon \u03b1-2a for progressive or recurrent craniopharyngiomas. J Neurosurg 92:255\u2013260","journal-title":"J Neurosurg"},{"key":"5001_CR154","doi-asserted-by":"crossref","unstructured":"Shah SN, Kaki PC, Shah SS, Shah SA (2023) Concurrent radiation and targeted therapy for papillary craniopharyngioma: A case report. Cureus 15","DOI":"10.7759\/cureus.40190"},{"key":"5001_CR155","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.6004\/jnccn.2020.7624","volume":"18","author":"K Khaddour","year":"2020","unstructured":"Khaddour K, Chicoine MR, Huang J et al (2020) Successful use of BRAF\/MEK inhibitors as a neoadjuvant approach in the definitive treatment of papillary craniopharyngioma. J Natl Compr Canc Netw 18:1590\u20131595. https:\/\/doi.org\/10.6004\/jnccn.2020.7624","journal-title":"J Natl Compr Canc Netw"},{"key":"5001_CR156","doi-asserted-by":"publisher","first-page":"bvab043","DOI":"10.1210\/jendso\/bvab043","volume":"5","author":"CL Chik","year":"2021","unstructured":"Chik CL, van Landeghem FKH, Easaw JC, Mehta V (2021) Aggressive Childhood-onset papillary craniopharyngioma managed with Vemurafenib, a BRAF inhibitor. J Endocr Soc 5:bvab043. https:\/\/doi.org\/10.1210\/jendso\/bvab043","journal-title":"J Endocr Soc"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05001-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-025-05001-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-025-05001-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T10:01:51Z","timestamp":1748253711000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-025-05001-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,10]]},"references-count":156,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["5001"],"URL":"https:\/\/doi.org\/10.1007\/s11060-025-05001-4","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,10]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics declaration"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}